Trader consensus on Polymarket prices a mere 8% chance of Anthropic being acquired before year-end 2026, driven by the AI lab's aggressive independence strategy. Recent acquisitions like stealth biotech startup Coefficient Bio for $400 million in April 2026 and Vercept in February underscore Anthropic as the acquirer, not target, bolstering its frontier AI capabilities in drug discovery and computer use. CEO Dario Amodei has rebuffed investor offers exceeding $800 billion valuation, amid $18 billion 2026 revenue forecasts and early IPO groundwork targeting a $300 billion-plus debut. Amazon and Google backers supply compute without seeking control. While compute shortages or intensified competition from OpenAI could theoretically spur a buyout, no credible talks exist, and self-sustainability via IPO appears the dominant path.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · AggiornatoSì
$14,758 Vol.
$14,758 Vol.
31 dic 2026
Sì
$14,758 Vol.
$14,758 Vol.
31 dic 2026
This market will resolve to “Yes” if credible reporting confirms that any entity enters into an agreement to acquire Anthropic by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.
Mergers where Anthropic is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between Anthropic and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from Anthropic and/or its leadership, however a consensus of credible reporting will also be used.Trader consensus on Polymarket prices a mere 8% chance of Anthropic being acquired before year-end 2026, driven by the AI lab's aggressive independence strategy. Recent acquisitions like stealth biotech startup Coefficient Bio for $400 million in April 2026 and Vercept in February underscore Anthropic as the acquirer, not target, bolstering its frontier AI capabilities in drug discovery and computer use. CEO Dario Amodei has rebuffed investor offers exceeding $800 billion valuation, amid $18 billion 2026 revenue forecasts and early IPO groundwork targeting a $300 billion-plus debut. Amazon and Google backers supply compute without seeking control. While compute shortages or intensified competition from OpenAI could theoretically spur a buyout, no credible talks exist, and self-sustainability via IPO appears the dominant path.
This market will resolve to “Yes” if credible reporting confirms that any entity enters into an agreement to acquire Anthropic by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.
Mergers where Anthropic is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between Anthropic and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from Anthropic and/or its leadership, however a consensus of credible reporting will also be used.
Mergers where Anthropic is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between Anthropic and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from Anthropic and/or its leadership, however a consensus of credible reporting will also be used.
Mercato aperto: Nov 12, 2025, 5:14 PM ET
Volume
$14,758Data di fine
31 dic 2026Mercato aperto
Nov 12, 2025, 5:14 PM ETResolver
0x65070BE91...This market will resolve to “Yes” if credible reporting confirms that any entity enters into an agreement to acquire Anthropic by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.
Mergers where Anthropic is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between Anthropic and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from Anthropic and/or its leadership, however a consensus of credible reporting will also be used.Trader consensus on Polymarket prices a mere 8% chance of Anthropic being acquired before year-end 2026, driven by the AI lab's aggressive independence strategy. Recent acquisitions like stealth biotech startup Coefficient Bio for $400 million in April 2026 and Vercept in February underscore Anthropic as the acquirer, not target, bolstering its frontier AI capabilities in drug discovery and computer use. CEO Dario Amodei has rebuffed investor offers exceeding $800 billion valuation, amid $18 billion 2026 revenue forecasts and early IPO groundwork targeting a $300 billion-plus debut. Amazon and Google backers supply compute without seeking control. While compute shortages or intensified competition from OpenAI could theoretically spur a buyout, no credible talks exist, and self-sustainability via IPO appears the dominant path.
This market will resolve to “Yes” if credible reporting confirms that any entity enters into an agreement to acquire Anthropic by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.
Mergers where Anthropic is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between Anthropic and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from Anthropic and/or its leadership, however a consensus of credible reporting will also be used.
Mergers where Anthropic is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between Anthropic and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from Anthropic and/or its leadership, however a consensus of credible reporting will also be used.
Volume
$14,758Data di fine
31 dic 2026Mercato aperto
Nov 12, 2025, 5:14 PM ETResolver
0x65070BE91...Trader consensus on Polymarket prices a mere 8% chance of Anthropic being acquired before year-end 2026, driven by the AI lab's aggressive independence strategy. Recent acquisitions like stealth biotech startup Coefficient Bio for $400 million in April 2026 and Vercept in February underscore Anthropic as the acquirer, not target, bolstering its frontier AI capabilities in drug discovery and computer use. CEO Dario Amodei has rebuffed investor offers exceeding $800 billion valuation, amid $18 billion 2026 revenue forecasts and early IPO groundwork targeting a $300 billion-plus debut. Amazon and Google backers supply compute without seeking control. While compute shortages or intensified competition from OpenAI could theoretically spur a buyout, no credible talks exist, and self-sustainability via IPO appears the dominant path.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · Aggiornato
Fai attenzione ai link esterni.
Fai attenzione ai link esterni.
Domande frequenti